New test for early detection of lung cancer measures tiny changes in the composition of the breath

April 19, 2017, Max Planck Society
New test for early detection of lung cancer measures tiny changes in the composition of the breath
Scientists can collect RNA molecules released from lung tissue and amplify them with the help of polymerase chain reaction (qRT-PCR). The molecules can serve as a diagnostic tool to detect cancer cells in the lungs. Credit: MPI f. Heart and Lung Research/ G. Barreto

"Inhale deeply ... and exhale." This is what a test for lung cancer could be like in future. Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have developed a method that can detect the disease at an early stage. To this effect, they investigated the presence of traces of RNA molecules that are altered by cancer growth. In a study on healthy volunteers and cancer patients, the breath test correctly determined the health status of 98 percent of the participants. The method will now be refined in cooperation with licensing partners so that it can be used for the diagnosis of lung cancer.

Most patients die within five years of diagnosis. One of the main reasons for this is the insidious and largely symptom-free onset of the disease, which often remains unnoticed. In the USA, high-risk groups, such as heavy smokers, are therefore routinely examined by CAT scan. However, patients can be wrongly classified as having the disease.

Together with cooperation partners, researchers at the Max Planck Institute for Heart and Lung Research have now developed a that is much more accurate. In their research, the diagnosis of cancer was correct in nine out of ten cases. The method is therefore reliable enough to be used for the routine early detection of lung cancer.

The researchers analyzed RNA molecules released from into expired breath, noting differences between healthy subjects and . Unlike DNA, the RNA profile is not identical in every cell. Several RNA variants, and therefore different proteins, can arise from one and the same DNA segment. In healthy cells, such variants are present in a characteristic ratio. The scientists discovered that cancerous and healthy cells contain different amounts of RNA variants of the GATA6 and NKX2 genes. Cancer cells resemble in the embryonic stage.

The researchers developed a method to isolate RNA molecules. Not only is their concentration in expired breath extremely low, but they are also frequently highly fragmented. The researchers then investigated the RNA profile in subjects with and without lung cancer and from these data established a model for diagnosing the disease. In a test of 138 subjects whose was known, the test was able to identify 98 percent of the patients with lung cancer. 90 percent of the detected abnormalities were in fact cancerous.

"The breath test could make the detection of early-stage lung cancer easier and more reliable, but it will not completely supplant conventional techniques," says Guillermo Barreto, a Working Group Leader at the Max Planck Institute in Bad Nauheim. "However, it can complement other techniques for detecting early cancer stages and reduce false-positive diagnoses."

The scientists will contribute to future large-scale clinical trials. Together with the technology transfer organization Max Planck Innovation, they are seeking licensing partners to develop the breath test to maturity and market it. They also hope to use RNA profiles for the early detection of other diseases. Tiny changes could produce tissue profiles, akin to an RNA fingerprint, that reveal diseased cells and allow for rapid treatment.

Explore further: Breath temperature test could identify lung cancer

More information: Aditi Mehta et al. Non‐invasive lung cancer diagnosis by detection ofandisoforms in exhaled breath condensate, EMBO Molecular Medicine (2016). DOI: 10.15252/emmm.201606382

Related Stories

Breath temperature test could identify lung cancer

September 8, 2014
The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study.

Simple, affordable breath test for lung cancer may give more patients a better chance for cure

June 9, 2016
A single breath may be all it takes to identify the return of lung cancer after surgery, according to a study posted online today by The Annals of Thoracic Surgery.

Sniffer dogs can be used to detect lung cancer

August 18, 2011
Sniffer dogs could be used for the early detection of lung cancer, according to new research published in the European Respiratory Journal.

Exhaled breath biomarker may detect lung cancer

October 28, 2013
Researchers at Cleveland Clinic recently discovered that lung cancer may be detected in patients by testing their exhaled breath. Preliminary studies suggest that an accurate exhaled breath biomarker could be developed for ...

Trial seeks to sniff out lung cancer

June 19, 2012
Cancer smells different. Past research has shown that dogs can detect lung cancer in a person’s breath with great accuracy. But dogs are  tricky to use as a diagnostic tool; what does it mean when a dog barks once ...

Breath analysis offers non-invasive method to detect early lung cancer

April 29, 2014
Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer. Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET ...

Recommended for you

Metastatic cancer gorges on fructose in the liver

April 26, 2018
Biomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifically, the research shows that cells originating from colorectal cancer ...

Breast cancer genes a real risk for men, too

April 26, 2018
(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

Blood cancer precursor found in 9/11 firefighters

April 26, 2018
A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...

Largest-ever study of thyroid cancer genetics finds new mutations, suggests immunotherapy

April 26, 2018
University of Colorado Cancer Center researchers recently completed the largest-ever study of thyroid cancer genetics, mining the data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid ...

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

April 26, 2018
Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation, which plays a major role in the development of cancers caused by KSHV. Richard ...

PARP-1 may be key to effectiveness of PARP inhibitors, and now researchers can image it

April 26, 2018
Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to PARP inhibitors in patients with ovarian cancer—and they've also proven they have a ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.